Autopsy report · NCT01450683

Study of Itraconazole in Castrate-resistant Prostate Cancer (CRPC) Post-chemotherapy

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.

“Low accrual”

The sponsor’s own words in the registry.

Life of this trial

Registered 1 year after it had already started.
Ran for about 7 months before it stopped.
4 participants enrolled.
Results were posted on the registry 3 years 5 months after it ended.

Vital statistics

Status: Terminated
Phase: Phase 2
Sponsor: Stanford University
Sponsor type: University, hospital or other
Conditions: Prostate Cancer; Prostatic Neoplasms; Castrate-resistant Prostate Cancer (CRPC); Androgen-insensitive Prostate Cancer; Hormone-refractory Prostate Cancer; Metastatic Disease
Interventions: Itraconazole
Participants: 4
Sites: 1
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.